Skip to main content

Advertisement

Log in

Comparison of CMT1A and CMT2: similarities and differences

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

To evaluate the clinical and electrophysiological similarities and differences between two large groups of patients with Charcot-Marie-Tooth disease, i.e. CMT1A and CMT2, we performed a post hoc comparison of clinical and electrophysiological data.

Most CMT1A and CMT2 patients had the classical CMT phenotype. Age of onset was significantly later in CMT2. Total areflexia was present in approximately half of the CMT1A patients whereas it was rare in CMT2. Foot deformities and weakness of knee extensor and foot dorsal flexor muscles were more frequent in CMT1A. Median nerve motor nerve conduction velocities (MNCV) were always less than 38 m/s in CMT1A patients, whereas this was also the case in 16% of the CMT2 patients. Sensory nerve conduction velocities showed less overlap. In both CMT1A and CMT2 CMAP and SNAP amplitudes were often reduced or not obtainable in the legs. In CMT1A, SNAP amplitude was more reduced and SNAP duration more prolonged than in CMT2.

We conclude that there are no robust clinical signs or symptoms that differentiate between CMT1A and CMT2 patients. Electrodiagnostical studies show a length-dependent motor and sensory axonal dysfunction in both CMT-types. Additional SNAP and SNCV evaluation may be helpful in focusing molecular genetic analysis in the occasional case of CMT2 showing slow motor nerve conduction velocities overlapping with CMT1A values. The reduction of CMAP and SNAP amplitudes in CMT1A is probably a combined effect of demyelination and axonal dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

CMAP:

Compound muscle action potential

CMT:

Charcot-Marie-Tooth disease

HMSN:

Hereditary motor and sensory neuropathy

MNCV:

Motor nerve conduction velocity

SNAP:

Sensory nerve action potential

SNCV:

Sensory nerve conduction velocity

References

  1. Antonellis A, Ellsworth RE, Sambuughin N, Puls I, Abel A, Lee-Lin SQ, Jordanova A, Kremensky I, Christodoulou K, Middleton LT, Sivakumar K, Ionasescu V, Funalot B, Vance JM, Goldfarb LG, Fischbeck KH, Green ED (2003) Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V Am J Hum Genet 72:1293–1299

    Article  PubMed  CAS  Google Scholar 

  2. Behse F, Buchthal F (1977) Peroneal muscular atrophy (PMA) and related disorders. II. Histological findings in sural nerves. Brain 100(1):67–85

    Article  PubMed  Google Scholar 

  3. Birouk N, Gouider R, Le Guern E, Gugenheim M, Tardieu S, Maisonobe T, Le Forestier N, Agid Y, Brice A, Bouche P (1997) Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 120:813–823

    Article  PubMed  Google Scholar 

  4. Bouche P, Gherardi R, Cathala HP, Lhermitte F, Castaigne P (1983) Peroneal muscular atrophy. Part 1. Clinical and electrophysiological study. J Neurol Sci 61:389–399

    Article  PubMed  CAS  Google Scholar 

  5. Buchthal F, Behse F (1977) Peroneal muscular atrophy (PMA) and related disorders. I. Clinical manifestations as related to biopsy findings, nerve conduction and electromyography. Brain 100(1):41–66

    Article  PubMed  Google Scholar 

  6. Davis CJ, Bradley WG, Madrid R (1978) The peroneal muscular atrophy syndrome: clinical, genetic, electrophysiological and nerve biopsy studies. I. Clinical, genetic and electrophysiological findings and classification. J Genet Hum 26:311–349

    PubMed  CAS  Google Scholar 

  7. De Jonghe P, Mersivanova I, Nelis E, Del Favero J, Martin JJ, Van Broeckhoven C, Evgrafov O, Timmerman V (2001) Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E. Ann Neurol 49:245–249

    Article  PubMed  Google Scholar 

  8. De Jonghe P, Timmerman V, Van Broeckhoven C (1998) 2nd Workshop of the European CMT Consortium: 53rd ENMC International Workshop on Classification and Diagnostic Guidelines for Charcot-Marie- Tooth Type 2 (CMT2-HMSN II) and Distal Hereditary Motor Neuropathy (distal HMN-Spinal CMT) 26–28 September 1997, Naarden, The Netherlands. Neuromuscul Disord 8:426–431

    Article  Google Scholar 

  9. Dorfman LJ (1984) The distribution of conduction velocities (DCV) in peripheral nerves: a review. Muscle Nerve 7:2–11

    Article  PubMed  CAS  Google Scholar 

  10. Dorfman LJ, Cummins KL, Abraham GS (1982) Conduction velocity distributions of the human median nerve: comparison of methods. Muscle Nerve 5:S148–S153

    PubMed  CAS  Google Scholar 

  11. Dyck PJ, Lambert EH (1968) Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 18:603–618

    PubMed  CAS  Google Scholar 

  12. Dyck PJ, Lambert EH (1968) Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch Neurol 18:619–625

    PubMed  CAS  Google Scholar 

  13. Evgrafov OV, Mersiyanova I, Irobi J, Van Den Bosch L, Dierick I, Leung CL, Schagina O, Verpoorten N, Van Impe K, Fedotov V, Dadali E, Auer-Grumbach M, Windpassinger C, Wagner K, Mitrovic Z, Hilton-Jones D, Talbot K, Martin JJ, Vasserman N, Tverskaya S, Polyakov A, Liem RK, Gettemans J, Robberecht W, De Jonghe P, Timmerman V (2004) Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet 36:602–606

    Article  PubMed  CAS  Google Scholar 

  14. Harding AE, Thomas PK (1980) The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103:259–280

    Article  PubMed  CAS  Google Scholar 

  15. Hoogendijk JE, De Visser M, Bolhuis PA, Hart AAM, De Visser BWO (1994) Hereditary motor and sensory neuropathy type I: Clinical and neurographical features of the 17p duplication subtype. Muscle Nerve 17:85–90

    Article  PubMed  CAS  Google Scholar 

  16. Kaku DA, Parry GJ, Malamut R, Lupski JR, Garcia CA (1993) Uniform slowing of conduction velocities in Charcot-Marie-Tooth polyneuropathy type 1. Neurology 43:2664–2667

    PubMed  CAS  Google Scholar 

  17. Kimura J (1989) Electrodiagnosis in Diseases of Nerve, Muscle: Principles and Practice. 2nd ed. F.A. Davis Co, Philadelphia

    Google Scholar 

  18. Kimura J, Machida M, Ishida T, Yamada T, Rodnitzky RL, Kudo Y, Suzuki S (1986) Relation between size of compound sensory or muscle action potentials, and length of nerve segment. Neurology 36:647–652

    PubMed  CAS  Google Scholar 

  19. Kimura J, Sakimura Y, Machida M, Fuchigami Y, Ishida T, Claus D, Kameyama S, Nakazumi Y, Wang J, Yamada T (1988) Effect of desynchronized inputs on compound sensory and muscle action potentials. Muscle Nerve 11:694–702

    Article  PubMed  CAS  Google Scholar 

  20. Kincaid JC, Minnick KA, Pappas S (1988) A model of the differing change in motor and sensory action potentials over distance. Muscle Nerve 11:318–323

    Article  PubMed  CAS  Google Scholar 

  21. Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinderer SR, Garbern J, Kamholz J, Shy ME (2000) Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 123:1516–1527

    Article  PubMed  Google Scholar 

  22. Lawson VH, Gordon SA, Bromberg MB (2003) Assessment of axonal loss in Charcot-Marie-Tooth neuropathies. Exp Neurol 184:753–757

    Article  PubMed  Google Scholar 

  23. Lewis RA, Li J, Fuerst DR, Shy ME, Krajewski K (2003) Motor unit number estimate of distal and proximal muscles in Charcot-Marie-Tooth disease. Muscle Nerve 28:161–167

    Article  PubMed  Google Scholar 

  24. Lewis RA, Sumner AJ (1982) The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies. Neurology 32:592–596

    PubMed  CAS  Google Scholar 

  25. Loprest LJ, Pericak-Vance MA, Stajich J, Gaskell PC, Lucas AM, Lennon F, Yamaoka LH, Roses AD, Vance JM (1992) Linkage studies in Charcot-Marie-Tooth disease type 2: evidence that CMT types 1 and 2 are distinct genetic entities. Neurology 42:597–601

    PubMed  CAS  Google Scholar 

  26. Lupski JR, De Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, Saucedo-Cardenas O, Barker DF, Killian JM, Garcia CA, Chakravarti A, Patel PI (1991) DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66:219–232

    Article  PubMed  CAS  Google Scholar 

  27. Mersiyanova IV, Perepelov AV, Polyakov AV, Sitnikov VF, Dadali EL, Oparin RB, Petrin AN, Evgrafov OV (2000) A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 67:37–46

    Article  PubMed  CAS  Google Scholar 

  28. Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, Barker DF, Martin JJ, De Visser M, Bolhuis PA, Van Broeckhoven C, Ceuterick C, De Winter G, Denayer P, Gheuens J, Jacobs K, Mercelis R, Raes G, Ringoet K, et al. (1991) Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). Neuromuscul Disord 1:93–97

    Article  PubMed  CAS  Google Scholar 

  29. Rothman KJ (1990) No adjustments are needed for multiple comparisons. Epidemiology 1:43–46

    Article  PubMed  CAS  Google Scholar 

  30. Tang BS, Zhao GH, Luo W, Xia K, Cai F, Pan Q, Zhang RX, Zhang FF, Liu XM, Chen B, Zhang C, Shen L, Jiang H, Long ZG, Dai HP (2005) Small heat-shock protein 22 mutated in autosomal dominant Charcot-Marie-Tooth disease type 2L. Hum Genet 116:222–224

    Article  PubMed  CAS  Google Scholar 

  31. Thomas PK, Marques W Jr., Davis MB, Sweeney MG, King RH, Bradley JL, Muddle JR, Tyson J, Malcolm S, Harding AE (1997) The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 120:465–478

    Article  PubMed  Google Scholar 

  32. Tjon-A-Tsien AM, Lemkes HH, Van der Kamp-Huyts AJ, Van Dijk JG (1996) Large electrodes improve nerve conduction repeatability in controls as well as in patients with diabetic neuropathy. Muscle Nerve 19:689–695

    Article  PubMed  CAS  Google Scholar 

  33. Van Dijk JG, Van der Kamp W, Van Hilten BJ, Van Someren P (1994) Influence of recording site on CMAP amplitude on its variation over a length of nerve. Muscle Nerve 17:1286–1292

    Article  PubMed  Google Scholar 

  34. Verhamme C, Van Schaik I, Koelman JH, De Haan RJ, Vermeulen M, De Visser M (2004) Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia J Neurol 251:1491–1497

    Article  PubMed  Google Scholar 

  35. Verhoeven K, De Jonghe P, Coen K, Verpoorten N, Auer-Grumbach M, Kwon JM, FitzPatrick D, Schmedding E, De Vriendt E, Jacobs A, Van Gerwen V, Wagner K, Hartung HP, Timmerman V (2003) Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet 72:722–727

    Article  PubMed  CAS  Google Scholar 

  36. Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S, Yang HW, Terada S, Nakata T, Takei Y, Saito M, Tsuji S, Hayashi Y, Hirokawa N (2001) Charcot-marie-tooth disease type 2a caused by mutation in a microtubule motor kif1bbeta. Cell 105:587–597

    Article  PubMed  CAS  Google Scholar 

  37. Zuchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, Zappia M, Nelis E, Patitucci A, Senderek J, Parman Y, Evgrafov O, Jonghe PD, Takahashi Y, Tsuji S, Pericak-Vance MA, Quattrone A, Battaloglu E, Polyakov AV, Timmerman V, Schroder JM, Vance JM (2004) Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 36:449–451

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank the Dutch patient organisation (Vereniging Spierziekten Nederland) for informing patients about the study and the patients for their participation. This study was supported by funds from the Prinses Beatrix Fonds, The Hague (HB and CV), and the Medical Research Council of the Netherlands organisation for Scientific Research (940-33-024, CV) The Hague, the Netherlands.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Camiel Verhamme.

Additional information

Drs. Bienfait and Verhamme contributed equally

Received in revised form: 20 March 2006

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bienfait, H.M., Verhamme, C., van Schaik, I.N. et al. Comparison of CMT1A and CMT2: similarities and differences. J Neurol 253, 1572–1580 (2006). https://doi.org/10.1007/s00415-006-0260-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-006-0260-6

Keywords

Navigation